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Abstract:  The natural products kahalalide F,  halichondrin B, and discodermolide are 
relatively large structures that were originally harvested from marine organisms. They are 
oxygen rich structures that, to varying degrees, should have the ability to bind iron (II or 
III) by Fe-O and/or Fe-N bonds. In this semi empirical study, the binding of these natural 
products to iron (II) is studied and the aqueous stability factor (ASF) is used to determine 
which bonding configuration is most stable. The energy, the complex charge (+1), the 
average Fe-O (or Fe-N) bond distances and the dipole moments are used to calculate the 
ASF. The ASF provides insight to which complex will be the most stable and water 
soluble, important for a medicinal application. The ability of a molecule with a more than 
six oxygen and/or nitrogen atoms to bind iron (hexavalent, octahedral) by shifting which 
six atoms (O/N) are bound to the iron qualifies it as a polarity adaptive molecule.  
 
Keywords: kahalalide F; halichondrin B; discodermolide; marine natural product; aqueous 
stability factor; computational  
 
1.  Introduction 
 
Past work in this lab with marine natural products (MNPs) has focused on experimental aspects 
associated with the marine natural product bryostatin, which is extracted from the bryozoa, Bugula 
neritina, and the pharmaceutical agent ET743 (Yondelis
TM) extracted from the sea squirt, 
Ecteinascidia turbinate. It is accepted that symbiotic microbes produce bryostatin and that this 
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substance may play a role in the defense of the host organism and/or be a siderophore. Our 
geochemical studies helped understand the chemical environment under which the symbiotic microbes 
that produce the marine natural products can thrive. This work led us to develop an approach to 
producing marine natural products called pharmaceutical aquaculture which is centered on a device 
called bacterial amplification chambers (BACs). During these projects we found that bryostatin was 
often bound to iron when it was extracted from the marine environment. This led us to postulate that 
bryostatin’s role in nature is that of the siderophore. Bryostatins structure features a bryophan ring 
lined by a number of oxygen atoms and suggests it has the ability to trap a cation, much like a 
siderophore or a crown ether. Our group has performed a number of semi-empirical computational 
studies aimed at determining if iron (III) or iron (II) could bind bryrostatin via an octahedral, 
hexavalent type geometry. This work was than extended to examining bryostatin analogs, some well 
known siderophores, some other natural products and taxol. From a pharmaceutical perspective, it was 
argued that iron binding to many of these natural products increased its water solubility, stabilized its 
structures and made the complex more rigid, perhaps allowing it to perform in a lock and key model 
more efficiently. In this computational study we are focused on the marine natural products kahalalide 
F, halichondrin B, and discodermolide.  
Discodermolide (Figure 1) is part of a class of anticancer drugs that target microtubules and has 
been shown to stimulate microtubule polymerization and stabilize microtubules at high concentrations 
similar to that of taxol [1,2].
 Discodermolide has better water solubility parameters and higher activity 
against some taxol-resistant cell lines.  Discodermolide was first extracted from the deep-water, 
Caribbean sponge, Discodermia dissolute, in 1990 [3]. It has been tested in different in vivo and in 
vitro  experiments and advanced to Phase I clinical trials [4–6]. A number of analogues of 
discodermolide have been synthesized, but maintain the carbon backbone [7].  
 
Figure 1. The two dimensional image of the marine natural product discodermolide. 
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Kahalalide F is a marine natural product that belongs to a family of compounds known as 
depsipeptides (see Figure 2) [8–13]. It is most commonly obtained from the Hawaiian saltwater 
mollusk, Elysia rufescens [8]. Kahalalide F has also been isolated from the green algae, Bryopsis 
pennat, which is part of E. rufescens diet. This finding suggests that kahalalide F is a secondary 
metabolite derived from the mollusk’s diet [9]. The structure of kahalalide F was first described by 
Hamann et al.; however, the stereochemistry of its more active form was later elucidated by Rinehart 
et al. [13]. Kahalalide F has been tested in multiple clinical trials and has been found effective against 
many human cancers, including prostate, breast, colon carcinomas, neuroblastoma, chondrosarcoma, Mar. Drugs 2010, 8  
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osteosarcoma, non-small-cell lung cancer, liver cancer, and melanoma. It has been shown to attack 
tumor cells via multiple mechanisms including; disruption of lysosomal membranes, inhibition of 
transforming factor-α expression, blockage of epidermal growth factor signaling pathways, and 
induction of non-p53 mediated apoptosis. Kahalalide F has been in clinical trials including patients 
with androgen refractory prostate cancer and advanced solid tumors [14–16]. 
 
Figure 2. The two dimensional structure of the marine natural product kahalalide F. 
Oxygen atoms are numbered 1–16 and nitrogen’s are numbered 1–14. 
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Figure 3. Halichondrin B has proven to be a difficult molecule to synthesize on a large, 
economical scale.  
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Halichondrin B was isolated from the Japanese sponge Halichondria Okada in 1985 by Uemura  
et al. [17]. Halichondrin B is a powerful polyether macrolide (see Figure 3). Since 1986, halichondrin 
B and its analogs have been found in several different sponges, but with a very low yield [18]. The 
National Cancer Institute has been interested in developing halichondrin B for preclinical trials, but 
has not followed through because harvesting and extraction efforts produced low yields. Halichondrin 
B has been shown to be a strong anticancer agent [19] especially in the treatment of leukemia and 
reducing tumors in other cancers including lung, pancreatic, and ovarian cancer. The first synthesis 
was completed by Namba et al. [20] which eventually led to the discovery of the halichondrin B 
analog, E7389 [21]. E7389 (Figure 4) has been proven to be more stable than halichondrin B and will Mar. Drugs 2010, 8  
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be discussed next. It is a synthetic analog of halichondrin B and acts as a microtubule modulator [22]. 
The total synthesis of E7389 has been accomplished and it has strong medicinal properties [23–25].  
 
Figure 4. A two dimensional structure of E7389. 
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In the figures above (1–3) the oxygen and nitrogen atoms are numbered and will be correlated with 
data presented below. Like many marine natural products, these structures are relatively large and 
difficult to synthesize and there has been no success in getting marine microbes to synthesize the three 
natural products in bulk. A key point to recognize is that the iron ion can move to different Fe-O 
and/or Fe-N bonds in the aqueous phase. By shifting from one Fe-O bond to another Fe-O bond the 
molecule shifts polarity and geometry. This ability to shift charge and shape allows the iron complex 
to adapt to different environments in a physiological environment. For example, a complex with a high 
dipole moment will have a higher solubility in water. If the iron shifts the specific oxygen atoms to 
which it is bound, the polarity can be lowered and will be more likely to penetrate a nonpolar cell wall. 
From our past work, we have dubbed this a polarity adaptive molecule. The reason to investigate the 
binding of these different molecules to iron is because it may enhance their medicinal activity.  
 
2. Results and Discussion 
 
The aqueous stability factor (ASF, Joules*meters/Debye or Jm/D)) is a term that combines four 
calculated parameters for the different metallic-marine natural product complexes; complex energy 
(E), average Fe-O bond length (L), charge (Z, +1, +2, etc.) and the dipole moment (D).  
ASF = (Complex Energy)(Average Bond Length)/(Dipole Moment)(Charge)   (1) 
= (E*L/D*Z) 
For a molecule to be stable, the calculated magnitude of the energy (E) should be small or negative. 
For strong Fe-O bonds, a small Fe-O average bond length indicates a great degree of covalency. In 
narrowing down the number of complexes, compounds with average bond distances of more than  
2.7 Å were discarded without considering other parameters and any single bond of more than 2.9 Å 
was considered to be close to lacking covalency and that complex was also not considered. For a 
molecule to have good water solubility, a desirable medicinal characteristic, a large dipole moment (D) Mar. Drugs 2010, 8  
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is desired. Also, larger charges (i.e., +2, +3) would improve water solubility but our mass spectral data 
(via FT-ICR, TOF-MS) on complexes like Fe-bryostatin-1 and Fe-taxol only suggested the +1 species 
was present. The smaller the aqueous stability factor, the more likely the complex is to have a 
physiological solubility and improved stability in vivo.  
While the dipole moment is used to calculate the ASF, it is also used to help understand the 
solubility of the solute in a common solvent (water, methanol, etc.). With the common solvents shown 
in Table 1, the dipole moment to volume ratio (D/V) extends from the polar solvent water (.090) to the 
nonpolar species hexane (0.00). Tables 2–5 provide results from this study for six Fe-O bonds where 
all six of the oxygen’s are part of the marine natural product and Tables 6–9 provide the computational 
results for complexes with five Fe-O bonds and one Fe-OH2 bond (see Figure 5). The iron still has an 
octahedral geometry with a hexavalent bonding scheme but experimental work with Fe-taxol and Fe-
bryostatin have shown that a water molecule can occupy one of the six coordination sites. The 
numbers in the first column of Tables 2–9 (i.e., 6, 7, 8, 9, 10, 11) are correlated with the oxygen and/or 
nitrogen atoms numbered in Figures 1–4. The average bond distance (column 3) is for the six Fe-O 
bond lengths that formed the hexavalent complex.  
 
Table 1. The calculated dipole moment (Debye, D), molecular volume (V, Å
3) and the 
D/V ratio for some common solvents.  
Name Dipole  Moment  Molecular Volume (V)  D/V 
Water  1.74 19.24  0.090 
Methanol  1.54 40.66  0.038 
Ethanol  1.48 59.08  0.025 
1-Propanol  1.59 77.37  0.020 
1-Butanol  1.60 95.69  0.017 
1-Pentanol  1.41 114.06 0.012 
1-Octanol  1.62 168.95 0.0096 
Hexane  0.00 124.80 0.00 
 
Tables 2, 3, 4, 5, 6 and 7 provide the calculated parameters for the most stable iron-kahalalide F, 
iron-halichondrin B and iron-discodermolide complexes. Over two-hundred complexes were built and 
studied for selection into these tables; those selected for these tables had the most stable ASF 
calculations. In table 2, 3, and 4 iron is taken as a hexavalent central atom with an octahedral geometry 
and all six oxygen and/or nitrogen atoms (6 Fe-O/Fe-N total) are from the MNP structure. In Tables 5, 
6 and 7 iron has the same geometric features but only five of the oxygen’s and/or nitrogen’s from the 
MNP are part of complexes inner sphere while the sixth coordination spot on the central atom is 
occupied by a water molecule (Fe-OH2).  
 Mar. Drugs 2010, 8  
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Table 2. The dipole moment (Debye), bond distances (Å), area (Å²), volume (Å³), 
dipole/volume ratio (D/Å³), molar mass (g/mol), average bond length (Å), energy 
(joules/mol), and aqueous stability factor (ASF) of ten Discodermolide molecules 
containing iron. 
 
Table 3. The dipole moment (Debye), bond distances (Å), area (Å²), volume (Å³), 
dipole/volume ratio (D/Å³), molar mass (g/mol), average bond length (Å), energy (joules), 
an aqueous stability factor of ten kahalalide F molecules containing iron. 
Oxygen/ 
nitrogen #’s 
Dipole  Distances  Area  Volume  D/V 
Molar 
mass 
Aver. 
Bond dist. 
Energy  ASF 
O1, O2, O3, 
O4, O5, O6 
11.17  1.957, 2.485, 1.964, 
2.456, 2.184, 2.253 
657.4  647.87  0.0172  646.625  2.2165  1073380.93  2.1299 × 10
-5 
O1, O2, O3, 
O4, O5, N1 
11.15  1.932, 2.471, 1.978, 
2.470, 2.253, 2.396 
650.0  647.51  0.0172  646.425  2.2500  1423974.61  2.8734 × 10
-5 
O1, O2, O3, 
O4, O8, N1 
8.12  1.900, 2.415, 1.999, 
2.412, 2.022, 2.005 
676.4  654.77  0.0124  648.641  2.1255  1131756.10  2.9625 × 10
-5 
O1, O2, O3, 
O4, O5, O8 
15.76  2.228, 2.444, 1.945, 
2.232, 2.208, 2.269 
660.4  654.66  0.0241  648.641  2.2210  1538512.45  2.1682 × 10
-5 
O1, O2, O3, 
O6, O7, N1 
12.86  2.425, 2.023, 2.015, 
1.984, 2.476, 2.160 
661.2  649.79  0.0198  647.633  2.1805  1456789.72  2.4701 × 10
-5 
O1, O2, O3, 
O5, O8, N1 
7.81  2.068, 2.051, 2.036, 
2.106, 1.965, 2.109 
656.3  653.23  0.0120  648.641  2.0558  888909.63  2.3400 × 10
-5 
O1, O3, O4, 
O6, O8, N1 
9.38  1.899, 1.883, 1.968, 
2.148, 1.904, 1.911 
655.4  650.65  0.0144  648.641  1.9522  643672.84  1.3396 × 10
-5 
O1, O3, O4, 
O7, O8, N1 
15.09  2.181, 2.128, 1.980, 
2.439, 2.036, 2.060 
667.7  655.45  0.0230  649.649  2.1373  1124527.40  1.5928 × 10
-5 
O1, O3, O4, 
O5, O7, O8 
16.44  2.418, 2.353, 2.210, 
2.249, 2.427, 2.079 
659.5  656.48  0.0250  649.649  2.2893  1723667.00  2.4003 × 10
-5 
O1, O2, O3, 
O6, O8, N1 
10.78  2.018, 2.122, 2.027, 
2.185, 2.043, 2.049 
670.6  654.56  0.0165  648.641  2.0740  795760.82  1.5310 × 10
-5 
Oxygen/ 
nitrogen # 
Dipole  Bond Distances  Area  Volume  D/V 
molar 
mass 
aver. bond 
length 
Energy  ASF 
N1, N2, N3,  18.04  2.499, 2.117, 2.519,  1507.1  1542.8  0.01169  1530.69  2.2373  1.160 × 10
6  1.44 × 10
-5 
O5, O6, O7    2.015, 2.237, 2.037               
N3, N4, N5,  22.96  2.409, 2.54, 2.338,  1570.5  1549.5  0.01482  1528.68  2.4077  1.931 × 10
6  2.03 × 10
-5 
N6, N7, O1    2.537, 2.576, 2.046               
N4, N5, N6,  20.38  2.472, 2.043, 2.435,  1568.9  1551.6  0.01313  1529.68  2.2800  1.785 × 10
6  2.00 × 10
-5 
N7, O1, O2    2.463, 1.962, 2.305               
N3, N4, N5,  25.59  2.478, 2.515, 2.232,  1554.4  1548.7  0.01652  1528.68  2.3548  1.854 × 10
6  1.71 × 10
-5 
N6, N7, O2    2.315, 2.543, 2.046               
N4, N5, N6,  23.16  2.492, 2.121, 2.418,  1562.0  1549.3  0.01495  1529.68  2.2795  1.691 × 10
6  1.66 × 10
-5 
N7, O2, O3    2.53, 2.076, 2.04               
N6, N7, O2,  23.35  2.499, 2.547, 2.29,  1501.7  1540.1  0.01516  1531.70  2.2952  2.055 × 10
6  2.02 × 10
-5 
O3, O4, O5    2.102, 2.482, 1.851               
N2, N4, N6,  19.82  2.497, 2.451, 2.111,  1564.3  1548.3  0.01280  1530.69  2.1905  1.128 × 10
6  1.25 × 10
-5 Mar. Drugs 2010, 8  
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Table 3. Cont. 
 
Table 4. The atom #’s, dipole moment (Debye), bond distances (Å), area (Å²), volume 
(Å³), dipole/volume ratio (D/Å³), molar mass (g/mol), average bond length (Å), energy 
(joules), an aqueous stability factor of ten halichondrin B molecules containing iron. 
 
O2, O4, O6    2.153, 1.991, 1.94               
O10, O11, O12,  19.94  2.363, 2.326, 2.46,  1513.3  1542.8  0.01292  1531.70  2.3483  1.686 × 10
6  1.99 × 10
-5 
O13, N13, N14    1.971, 2.512, 2.458               
O10, O11, O12,  20.68  2.360, 2.17, 2.085,  1485.6  1540.3  0.01343  1530.69  2.2930  1.316 × 10
6  1.46 × 10
-5 
N12, N13, N14    2.396, 2.26, 2.487               
N11, N12, N13,  19.99  2.337, 2.012, 2.288,  1513.9  1543.0  0.01300  1529.68  2.2860  1.262 × 10
6  1.44 × 10
-5 
N14, O10, O11    2.465, 2.157, 2.457               
Oxygen #’s  Dipole  Distance  Area  Volume  D/V 
Molar 
mass 
Avg. bond 
distance 
Energy  ASF 
1,2,3,5,6,7  13.87  2.639, 2.647, 2.574, 
2.453, 2.684, 2.706 
945.71  1060.93  0.01307  1167.57  2.617  3674624.  6.9 × 10
-5 
3,5,6,7,9,10  19.67  2.540, 2.488, 2.664, 
2.710, 2.697, 2.727 
1030.39  1080.05  0.01821  1167.57  2.194  7393466.  8.0 × 10
-5 
1,3,5,6,7,9  15.91  2.682, 2.540, 2.462, 
2.695, 2.710, 2.683 
941.03  1069.44  0.09596  1167.57  2.629  6085918.  1.0 × 10
-4 
1,2,3,6,7,10  19.94  2.717 , 2.718, 2.664, 
2.730, 2.680, 2.686 
893.96  1051.35  0.01897  1167.57  2.699  -4685181.  -6.3 × 10
-5 
2,5,7,9,10,12  7.55  2.729, 2.769, 2.750, 
2.782, 2.592, 2.729 
930.78  1057.96  0.00714  1167.57  2.720  6953.642  2.5 × 10
-7 
1,3,5,6,7,10  18.78  2.673, 2.528, 2.526, 
2.725, 2.728 
1016.45  1076.59  0.01744  1167.57  2.649  7292712.  1.0 × 10 
-4 
2,3,5,6,7,14  8.60  2.724, 2.482, 2.586, 
2.710, 2.719, 2.772 
887.65  1046.50  0.00822  1167.57  2.666  1394772.  4.3 × 10
-5 
14,15,16,17,18,19  11.75  2.687, 1.886, 2.614, 
2.318, 2.219, 1.999 
1027.22  1076.81  0.01091  1166.57  2.287  2559699.  5.0 × 10
-5 
1,14,16,17,18,19  11.31  2.634, 2.692, 2.699, 
2.401, 2.084, 1.946 
976.65  1065.90  0.01061  1166.60  2.416  3294402.  7.0 × 10
-5 
1,15,16,17,18,19  10.84  2.613,2.502, 2.616, 
2.103, 2.255, 1.984 
991.43  1071.33  0.01012  1166.57  2.059  3577592.  6.8 × 10
-5 Mar. Drugs 2010, 8  
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Table 5. The dipole moment (Debye), bond distances (Å), area (Å²), volume (Å³), 
dipole/volume ratio (D/Å³), molar mass (g/mol), average bond length (Å), energy 
(joules/mol), and aqueous stability factor (ASF) of ten Discodermolide molecules 
containing iron bound to water.  
 
Table 6. The dipole moment (Debye), bond distances (Å), area (Å²), volume (Å³), 
dipole/volume ratio (D/Å³), molar mass (g/mol), average bond length (Å), energy (joules), 
and aqueous stability factor of ten Kahalalide F molecules containing iron bound to water. 
Oxygen-
nitrogen #’s 
Dipole  Distance  Area  Volume  D/V 
Molar 
mass 
Aver. 
Bond Dist. 
Energy  ASF 
H2O, O2, O3, 
O6, O8, N1 
14.47  2.559, 2.091, 2.051, 
2.237, 2.038, 2.118 
704.04  674.36  0.0215  666.656  2.1823  787597.4  1.1878 × 10
-5 
O1, O2, O3, 
H2O, O8, N1 
13.73  2.003, 2.122, 2.009, 
2.547, 2.094, 1.995 
706.77  675.37  0.0203  667.664  2.1283  685588.1  1.0628 × 10
-5 
H2O, O2, O3, 
O4, O5, O6 
13.57  2.554, 2.350, 2.141, 
2.446, 2.203, 2.213 
690.23  669.93  0.0203  664.640  2.3178  814118.9  1.3906 × 10
-5 
O1, O2, O3, 
H2O, O5, O6 
11.64  2.237, 2.217, 2.001, 
2.530, 2.111, 2.117 
692.78  669.60  0.0174  665.648  2.2022  614768.0  1.1631 × 10
-5 
O1, O2, O3, 
H2O, O5, O8 
26.10  2.049,2.085, 2.018, 
2.537, 2.211, 2.198 
699.71  675.36  0.0386  667.664  2.1830  820896.2  6.8660 × 10
-6 
H2O, O2, O3, 
O6, O7, N1 
27.13  2.532, 2.071, 2.132, 
2.010, 2.392, 2.063 
699.23  670.70  0.0405  665.648  2.2000  1155916.  9.3734 × 10
-6 
O1, O2, O3, 
O4, O8, H2O 
21.48  1.933, 2.434, 1.962, 
2.366, 2.267, 2.519 
712.92  676.72  0.0317  667.664  2.2468  1109704.3  1.1608 × 10
-5 
H2O, O3, O4, 
O7, O8, N1 
13.61  2.524, 2.074, 2.055, 
2.286, 2.047, 2.136 
709.82  676.42  0.0201  667.664  2.1870  801772.3  1.2884 × 10
-5 
O1, O3, O4, 
H2O, O8, N1 
14.10  2.015, 2.108, 2.011, 
2.533, 1.981, 2.003 
710.93  676.08  0.0209  667.664  2.1085  865660.4  1.2945 × 10
-5 
H2O, O3, O4, 
O5, O7, O8, 
26.56  2.552, 2.390, 2.322, 
2.244, 2.155, 2.100 
696.62  677.37  0.0392  667.664  2.2938  1399399.8  1.2086 × 10
-5 
Oxygen-
nitrogen #’s 
Dipole 
(Debye) 
Distance  Area  Volume  D/V 
Molar 
mass 
Ave. bond 
length 
Energy  ASF 
H2O, N1, N2,  19.52  2.438, 2.332, 2.55,  1535.1  1564.71  0.012475  1549.71  2.2488  1.28 × 10
6  1.48 × 10
-5 
O5, O6, O7     1.946, 2.225, 2.002                      
H2O, O6, O7,  13.76  2.479, 2.121, 2.477,  1570.3  1565.01  0.008792  1548.71  2.3408  8.64 × 10
5  1.47 × 10
-5 
N1, N2, N3     2.556, 2.446, 1.966                      
H2O, O2, O3,  27.44  2.427, 2.373, 2.44,  1574.0  1566.24  0.017519  1548.71  2.3018  1.77 × 10
6  1.48 × 10
-5 
N4, N5, N6     2.58, 1.906, 2.085                      
H2O, N4, N6,  23.48  2.535, 2.147, 2.017,  1588.7  1566.91  0.014984  1549.71  2.1355  1.12 × 10
6  1.02 × 10
-5 
O2, O4, O6     1.972, 2.147, 1.995                      Mar. Drugs 2010, 8  
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Table 6. Cont. 
 
Table 7. The dipole moment (Debye), bond distances (Å), area (Å²), volume (Å³), 
dipole/volume ratio (D/Å³), molar mass (g/mol), average bond length (Å), energy (joules), 
and aqueous stability factor of ten halichondrin B molecules containing iron bound   
to water. 
 
 
H2O, O4, O6  15.97  2.424, 2.362, 2.437,  1576.2  1567.12  0.010190  1548.71  2.2847  8.52 × 10
5  1.22 × 10
-5 
N2, N4, N6     2.56, 1.978, 1.947                      
H2O, O10, O12,  23.74  2.379, 2.587, 2.135,  1558.6  1564.31  0.015170  1548.71  2.361  1.23 × 10
6  1.22 × 10
-5 
N12, N13, N14     2.268, 2.297, 2.5                      
H2O, O10, O11,  25.02  2.198, 2.082, 2.58,  1524.4  1562.13  0.016016  1548.71  2.3227  1.38 × 10
6  1.28 × 10
-5 
N12, N13, N14     2.281, 2.253, 2.542                      
H2O, O10, N11,  36.57  2.131, 2.588, 2.504,  1563.9  1565.28  0.023363  1547.70  2.4075  1.56 × 10
6  1.02 × 10
-5 
N12, N13, N14     2.262, 2.405, 2.555                      
H2O, O10, O11,  20.90  2.126, 1.923, 2.338,  1534.3  1561.66  0.013383  1548.71  2.3348  1.30 × 10
6  1.45 × 10
-5 
N11, N12, N14     2.494, 2.602, 2.526                      
H2O, O10, O11,  22.12  2.347, 1.958, 2.461,  1559.1  1532.94  0.014429  1548.71  2.3022  1.14 × 10
6  1.19 × 10
-5 
N11, N12, N13     2.102, 2.377, 2.568                      
Oxygen #’s  Dipole  Distance  Area  Volume  D/V  MW 
Aver 
bond dist 
Energy  ASF 
1,3,5,6,7,H2O  16.96  Fe-O1: 2.638, 1.88, 2.472, 
2.211, 2.582, 2.659 
971.93  1085.69  0.0156  1167.57  2.407  3103.006  4.4 × 10
-8 
2,3,6,7,10,H2O  17.89  Fe-H2O: 2.557, 2.128, 
1.948, 2.512, 2.394, 2.301 
952.20  1080.52  0.0166  1185.57  2.307  -1780.230  -2.3 × 10
-8 
1,2,3,7,10,H2O  10.73  Fe-O1: 2.327, 2.455, 
5.367, 2.59, 2.054, 2.498 
982.86  1086.39  0.0099  1185.57  2.382  -2600.840  -5.8 × 10
-8 
2,3,5,6,7,H2O  16.77  Fe-O2: 2.498, 1.848, 
1.993, 2.314, 2.453, 2.498 
966.88  1082.15  0.0155  1118.57  2.270  -125.424  -1.7 × 10
-9 
15,16,17,18,19, H2O  14.25  Fe-H2O: 2.511, 2.535, 
2.483, 2.151, 2.25, 1.997 
1057.85  1095.69  0.0130  1185.57  2.320  2657.263  4.33 × 10
-8 
14,16,17,18,19,H2O  15.12  Fe-H2O: 2.492, 2.631, 
2.618, 2.268, 2.154, 1.997 
1047.75  1093.53  0.0138  1185.57  2.360  2512.387  3.92 × 10
-8 
1,16,17,18,19,H2O  13.27  Fe-O1: 2.572, 2.516, 
2.533, 2.088, 2.386, 2.033 
1020.44  1089.88  0.0122  1185.57  2.350  2201.572  3.9 × 10
-8 
1,14,16,18,19,H2O  19.50  Fe-O1: 2.574, 2.642, 
2.701, 2.558, 2.104, 1.951 
1009.10  1085.79  0.0178  1185.57  2.420  2320.397  2.88 × 10
-8 
15,16,17,18,19,H2O  16.02  Fe-H2O: 2.510, 2.538, 
2.484, 2.149, 2.259, 2.00 
1057.95  1095.55  0.0146  1185.57  2.323  2657.028  3.85 × 10
-8 
1,16,17,18,19,H2O  12.83  Fe-O1: 2.562, 1.955, 
2.553, 2.239, 2.221, 2.017 
1023.60  1090.34  0.0118  1185.57  2.258  2189.281  3.85 × 10
-8 Mar. Drugs 2010, 8  
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Table 8. The average values for approximately fifty complexes of each iron species. 
Species Area  Volume 
Dipole 
Moment 
D/V ABL Energy  ASF_Best  Average  ASF 
Fe-Hali  949.7  1065.0  8.82  0.0110  2.627  6307365  -0.0000634  0.000253 
Fe-Hali-H2O  991.7 1087.2  13.83  0.0126 2.483  3946000 0.00000086 -5.77E-08 
Hali  1036.5  1071.7  2.48  0.0023    1491027     
Fe-Disco  656.4 650.6  6.48  0.0100 2.231  1787000 0.0000153  0.00389 
Fe-Disco_H2O  697.2  673.2  10.68  0.0159  2.211  1090000  0.00000686  0.0000281 
Disco  689.9 650.9  4.84  0.0074    135515     
Fe-Kah  1537.0  1546.6  15.99  0.0103  2.283  2005200  0.00001246  0.00156 
Fe-Kah-H2O  1565.9 1565.1  19.04  0.0121  2.325  1551000 0.00001988  0.000003406 
Kah  1584.3  1548.0  4.82  0.0031    853007     
 
Figure 5. Iron has an octahedral geometry with six coordination sites. (left) In some 
calculations all six sites are occupied by oxygen and/or nitrogen atoms that are part of the 
marine natural product. In the other calculations (right) five of the six sites are occupied by 
oxygen and/or nitrogen atoms from the marine natural product and the sixth site is 
occupied by a water (solvent) molecule.  
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Figure 6 shows the correlation between the average bond length (ABL) in the iron-Discodermolide 
(Fe-Dis) complex and the calculated ASF. While there is not a strong correlation, short Fe-O and Fe-N 
bonds are critical for a strong metallic complex. These bonds are also dynamic in that the Fe-O and  
Fe-N bonds are constantly breaking and forming. The fifty most favorable (lowest ASF) complexes are 
presented in the graph and the individual values for the ten most favorable complexes are given in 
table 2. Tables two through seven also provide the individual bond distances for the ten most favorable 
complexes. Figure 6 is indicative of the three complexes regarding the lack of impact of the ABL on 
the ASF’s for the complexes studied here. While the ASF values can vary up to an order of magnitude 
for the different complexes, the ABL values are typically within 10–15% of each other.  
Figures 7, 8, 13, and 14 illustrate the poor correlation between the complexes surface areas and 
volumes and the ASF for the Fe-Dis and Fe-Dis-H2O. Although not presented, other complexes show a 
similar poor correlation for volumes and surface areas plotted against the ASF. While these graphs 
indicate no significant impact of the volume or surface area on the ASF, it may play a role in the ASF Mar. Drugs 2010, 8  
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and the Dipole Moment/Volume (D/V) ratios. Given that any natural product can interact with a 
protein, DNA, RNA, cell wall, etc., shifts in its geometry should be considered an important parameter 
in medicinal applications. Although not understood now, correlating these parameters with its 
medicinal activity as well as side effects may be explained in the future. As the ratio of area to the 
volume (A/V) approaches one, the ASF gets smaller suggesting a complex with the same surface area 
and volume would be the ideal candidate for water solubility and stability. While the volumes of the 
fifty most stable complexes vary by approximately 17 Å
3, the volumes of the ten most stable 
complexes vary over a smaller range (5 Å
3).  
Figure 8 indicates a small correlation between the calculated dipole moment of the Fe-Dis 
complexes and the ASF. This should be expected since increasing the dipole moment increases its 
water solubility. Figure 9 illustrates a modest correlation between the complexes energy and the ASF. 
High energy values were eliminated by setting upper limits on Fe-O and Fe-N bond distances 
considered (longer bond distances = higher energies and lower stabilities). Figures 10 and 11 illustrates 
the correlation between the dipole moment and the ASF, and the D/V (dipole moment/volume) ratio 
and the ASF, respectfully. While the D/V ratio is a better indicator of solubility in a specific solvent, 
the dipole moment of the different Fe-Dis complexes is used to calculate the ASF (Equation 1). 
Despite this dependency, the D/V ratio shows a better correlation verses the ASF than does the dipole 
moment (0.4878 vs. 0.5859).  
 
Figure 6. The average bond length (Å) plotted against the aqueous stability factor (Jm/D) 
for discodermolide bound to iron only. The best fit equation is a polynomial   
y = -3*10
6x
2 + 1693.9x + 2.1305 which gave a correlation coefficient of R² = 0.2543.  
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Figure 7. The area (Å
2) plotted against the aqueous stability factor (Jm/D) for 
discodermolide bound to only iron. The best fit equation is a polynomial   
y = 3*10
8x
2 - 134702x + 664.51 and a correlation coefficient of R² = 0.1468.  
 
 
Figure 8. The volume (Å
3) plotted against the aqueous stability factor (Jm/D) for 
discodermolide bound to iron only. The best fit equation for the data set is the polynomial  
y = 6*10
7x
2 - 31647x + 652.51 (R² = 0.0749).  
 
 
Figure 9. The energy (joules/mol) plotted against the aqueous stability factor (Jm/D) for 
discodermolide bound to iron only. The best fit equation for this correlation is the 
polynomial y = -3*10
13x
2 + 2E+10x + 838341 (R² = 0.4491).  
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Figure 10. The dipole moment (Debye) plotted against the aqueous stability factor (Jm/D) 
for discodermolide bound to iron only. The best fit equation for the data set is the 
polynomial y = -3.177ln(x) - 24.188 with a correlation coefficient of R² = 0.4878.  
 
 
Figure 11. The dipole moment to volume ratio (D/Ǻ
3) plotted against the aqueous stability 
factor (Jm/D) for discodermolide bound to iron only. The best fit equation is   
y = 3*10
-05x
-0.576 (R² = 0.5859).  
 
 
Figure 12. The average bond length (Å) plotted against the aqueous stability factor (Jm/D) 
for the Fe-Dis-H2O complex. The best fit line was determined to be the polynomial   
y = -5*10
6x
2 + 1408x + 2.1771 (R² = 0.0867). 
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Figure 13. The area (Ǻ
2) plotted against the aqueous stability factor (Jm/D) for the   
Fe-Dis-H2O complex. The best fit line is y = 706.59e
-475x (R² = 0.3831).  
 
 
Figure 14. The volume (Å
3) plotted against the aqueous stability factor (Jm/D) for the  
Fe-Dis-H2O complex. The best fit equation was determined to be   
y = 1*10
9x
2 - 154248x + 676.07 (R² = 0.0943).  
 
 
Table 5 provides the ten most favorable complexes for the iron-discodermolide-water (Fe-Dis-H2O) 
compound. Figure 12 provides the correlation between the average bond lengths for 50 of the water 
containing complexes. The average bond length over all 50 complexes is slightly longer than the 
average bond length for the 50 complexes with no water (2.17 Å vs. 2.13 Å) and, while there is a 
general range the general bond distances and ASF fall within, there is no correlation between the two 
parameters. The average surface area (Figure 13) increases from the Fe-Dis to the Fe-Dis-H2O 
complex from an average of 664 Å
2 to 707 Å
2. This increase in surface area is similar to that of an 
individual water molecule (36.4 Å
2). The average volume (Figure 14) for the fifty complexes (676 Å
3) 
for the water containing complex is larger than the dehydrated complex (652 Å
3) by an amount that is 
similar to the volume of the water molecule (19.4 Å
3). The average area for the fifty water containing 
complexes varies by as much as 50 Å
2 while the volume parameters are all within 12 Å
3 of each other Mar. Drugs 2010, 8  
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which suggests the different complexes should have similar densities but the different surface areas 
may lend themselves to different levels of activities. Figure 15 illustrates a strong correlation between 
the calculated dipole moment and the ASF and Figure 16 shows a slightly stronger correlation with the 
D/V ratio for the Fe-Dis-H2O complexes. The higher D/V ratio’s represent more polar complexes. A 
value in the 0.04–0.045 range should be soluble in a solvent such as ethanol or methanol with some 
solubility in water. The other end of the D/V scale is 0.005 which would indicate solubility in a low 
polarity solvent (i.e., octanol) or a nonpolar solvent (i.e., hexane). This range of values indicates that 
the Fe-Dis-H2O complex is a polarity adaptive molecule.  
 
Figure 15. The dipole moment (Debye) plotted against the aqueous stability factor (Jm/D) 
for the Fe-Dis-H2O complex. The best fit line for this data set is y = 0.0085x
-0.661 with a 
correlation coefficient of R² = 0.6993.  
 
 
Figure 16. The dipole moment to volume ratio (D/Ǻ
3) plotted against the aqueous stability 
factor (Jm/D) for the Fe-Dis-H2O complex.  The best fit equation for this data set is   
y = 1*10
-05x
-0.659 (R² = 0.6974).  
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Figure 17 shows a modest correlation between the energy and the ASF. The average energy for the 
Fe-Dis-H2O complexes are lower than the Fe-Dis complex (704.7 kJ vs. 838.8 kJ) indicating that the 
solvent will enter the inner sphere of the octahedral complex and stabilize it. Also, the average dipole 
moment for the fifty Fe-Dis-H2O complexes is 13.36 Debye while the average for the fifty Fe-Dis is 
8.39 Debye. The range of dipole moments is larger for the Fe-Dis-H2O complex compare to the Fe-Dis 
indicating a wider range of polarities it can adapt to in a physiological environment. The addition of 
the polar water molecule to the complex results in a significant increase in average polarity and   
the ASF. 
 
Figure 17. The energy (joules) plotted against the aqueous stability factor (Jm/D) for the 
Fe-Dis-H2O complex. The best fit equation was the polynomial   
y = -4*10
13x
2 + 2E+10x + 704724 (R² = 0.4903).  
 
 
When plotted, the Fe-Hali and Fe-Hali-H2O complexes also show little correlation for the same 
paramters. For the average dipole moments and correlation coefficients of the Fe-Kah (15.99 D, 
0.4697) and Fe-Kah-H2O (19.04 D, 0.0626) show an increase in the average calculated dipole moment 
for the water containing complex. The average D/V ratio, which is a better measure of water solubility 
than just the dipole moment for larger complexes, for the Fe-Kah (0.0103 D/Å
3) is slightly lower than 
the D/V for the Fe-Kah-H2O (0.0121 D/Å
3)) but both have similar or improved correlation verses the 
ASF compared to just the dipole moment. The average energy for the fifty Fe-Kah (2.005 MJ) is 
higher than the fifty Fe-Kah-H2O complexes (1.55 MJ) indicating that, on average, these complexes 
are less than when dehydrated. In both groups of complexes the correlation between the energy and the 
ASF is more significant than most of the other parameters discussed.  
Table 8 and Figures 18, 19 and 20 provide a summary of the average values given for each set of 
complexes. Figure 18 is a plot of the average energies for the different complexes verses the aqueous 
stability constant. Figure 19 shows that the average volumes and average surfaces are all closely 
correlated in that the ratio (V/A) is slightly less than one for most complexes. The energy does show a 
strong correlation with the complexes dipole moments for the averages of the six groups of iron 
complexes (Figure 20). On the other hand, the correlation between the energy and the D/V ratio drops Mar. Drugs 2010, 8  
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significantly (see Figure 21). Overall, the lower energy complex producing a species with a lower 
dipole moment may not be desirable for medicinal applications. Typically a high dipole moment 
results in high water stability and low energies means a more stable complex. Reviewing the 
noncomplexed values (no Fe) in table eight of the three marine natural products shows a lower energy 
or more stable species–but they also have lower dipole moments and lower D/V ratios than the iron 
complexes. This lower water solubility justifies the use of iron as a solubility enhancement agent for 
medicinal applications.  
 
Figure 18. Using the data in table 8, the average values for the ASF for the fifty more 
stable complexes of the different structure (Fe-Hali, Fe-Hali-H2O, etc.) is plotted against 
their energy (x-axis, J) and gives essentially no correlation represented by the best fit 
polynomial y = -7E+10x
2 - 8E+07x + 3E+06 (R² = 0.0774).  
 
 
Figure 19. The average ratio of volume to surface area, both calculated in Å, is close to 
1.0. The best fit line for the data from table 8 gives a straight line fit of   
y = 0.9934x + 38.626 (R² = 0.9787).  
 
 Mar. Drugs 2010, 8  
 
 
 
18
Figure 20. The correlation between the calculated energy and the dipole moment for the six 
groups of complexes gives a strong correlation. (y = 1E+07x - 3E+07, R² = 0.9397).  
 
 
Figure 21. The average energy of the six groups is plotted against the calculated D/V ratio 
and gives no correlation indicating there is little correlation between solubility and the 
complexes energy (y = 4013x
-1.432, R² = 0.1416).  
 
 
3. Materials and Methods 
 
The calculations were performed in Semiempirical (PM3) mode and all Fe-molecule complexes 
were assigned a charge of +1. The software used in these calculations is the Spartan Linux/cluster 
version (Wavefunction Inc, Irvine, CA, USA). The SUN Microsystem cluster was the hardware used 
to calculate the values used in this paper (Tables 1–7). For each molecule, up to one-hundred different 
Fe-MNP structures (up to fifty with six bonds to molecule, and up to fifty with five bonds to molecule 
and one to water) were built and calculated. Because of the sheer quantity of structures this study 
examined we sought to use semi-empirical, as opposed to ab initio, calculations. A single, high 
accuracy energy value is not considered important but rather the trends of energy values between 
different complexes. Likewise, a single conformation was not sought for any complex. Because of the Mar. Drugs 2010, 8  
 
 
 
19
dynamic nature of these structures in a physiological environment, a single conformation was never 
considered as a viable approach to understand their polarity. A well studied analogy is the MRI 
contrast reagent Gd-DTPA (Gadolinium(III) - diethylenetriaminepentaacetic acid). The exchange rate 
of water between the inner and outer sphere of the complex occurs on the order of 10
6 s
-1 [26]. This 
involves water displacing a carboxylate on one of Gd(III)’s eight coordination sites.  
Gd-DPTA
x+(aq) + H2O(l) Î Gd(H2O)DTPA
x+(aq)       (2) 
Although only projected at this point, all three complexes outlined in this study should be dynamic 
in both its conformations and how it binds Fe(III) or (II). Conformational energies were evaluated 
using the Molecular mechanics SYBYL force field. A molecule with a large number of single bonds in its 
backbone, each having three staggered rotamers, will have a large number of conformations. For 
example, discodermolide with 15 single bonds (fig. 1), can have up to 14,348,907 (3
15) conformations. 
Many of these structures will blend together so the actual number of unique conformations will be 
significantly lower than this value. Energy minimization was used to find the lowest energy structure, 
assuming a unique Fe-MNP geometry with a hexavalent, octahedral geometry, for each metal-ligand 
complex. This low energy structure was then used in the semiempirical calculations.  
Molecules with smaller numbers of oxygen and/or nitrogen atoms limited the number of 
configurations. Of these possible one hundred structures for each iron-MNP complex, the ten most 
stable were selected for the six Fe-MNP and the ten most stable were selected for the five Fe-MNP; 
one Fe-OH2 complexes. Then National Cancer Institutes’ Compare program and data 
(http://dtp.nci.nih.gov/compare/ ) was used to obtain the GI50 values for halichrodrin.  
 
4. Conclusions 
 
This computational project is focused on showing that three well known marine natural products are 
also polarity adaptive molecules [27–29]. Polarity adaptive molecules are involved in complexes with 
cations, in this case iron(II), and can shift dipole moments, as well as other parameters (average bond 
length, area, volume, energy) by shifting which five or six atoms the molecule attaches to iron. 
Currently we are working on similar calculations with five other molecules (E7389, dolastatin, 
piperazimycin, hibarimicin, and aplidine). Our ultimate computational exercise will be to attempt to 
correlate GI50 (growth inhibition) values taken from the National Cancer Institute’s five dose, 60 cell 
line panel and determine if there is a correlation of those values for the various cell lines and the ASF 
factor.  
In a large molecule, dipole moments can take on a different meaning than with a small species such 
as water or carbon dioxide. In a past study, our group showed that the polarity of a large molecule 
should be considered in sections when selecting a solvent [30]. In a large molecule a number of 
conformations are possible and a cation, such as iron (II) can bind it in a number of ways. What this 
study shows is that depending on conformation and depending on where the cation binds the species, 
which is a dynamic process, the individual parameters, such as dipole moment, volume, area, bond 
lengths, etc. will vary. With the iron added, the distribution of these values varies over a wider range. 
Typically molecules are thought of having a specific polarity and subsequently a specific solubility in 
a certain solvent or a specific solubility in a physiological environment. This work is not intended to Mar. Drugs 2010, 8  
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focus on a specific molecular geometry or dipole moment but to show that these values are distributed 
over a range of values. This distribution of values is important as the medicinal agent travels through 
physiological environment and senses environments with different polarities.  
Figure 22 shows a projected correlation between the log of the calculated ASF values for the   
Fe-halichondrin B complexes plotted against the Log(GI50) values for halichondrin B verses the 
National Cancer Institute’s (NCI) 60 cell line test(s). The COMPARE program available through 
NCI’s DTP web site was used to download the data. The data sets log(ASF) and log(GI50) were sorted 
highest to lowest and plotted against each other . The NCI cell line tests represent a range of cancers 
(CNS, melanoma, prostate, breast, etc.) and different genetic variations within each type of cancer. 
While the GI50 values, which are determined experimentally, and the calculated ASF values, cannot be 
directly correlated at this stage, we would like to offer the following projection and use Figure 22 as a 
potential example. First halichodrins medicinal value will be altered if administrated as an iron (II) or 
iron (III) complex. Second, if uncomplexed halichrodrin B is administrated its ability as a 
pharmaceutical may be correlated with the concentration of various cations (Fe
3+, Fe
2+, Ca
2+, Zn
2+, 
etc.) in the cancerous area. The cations can bind and either inhibit or improve the drug’s efficacy. 
Different genetic variations of the same disease may have different iron levels and subsequently 
interact with the molecule to different degrees [31]. 
Figure 22. After being sorted by magnitude, the log(GI)50  for halichondrin is plotted 
against the log(ASF). The best fit equation is y = 1.3375x
2 + 17.258x + 46.007   
(R² = 0.9509). 
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